Amalgam Rx
PrivateLast Round
Debt
Aug 12, 2025
Total Funding Raised
$46.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Amalgam Rx is a digital health company that provides a modular platform with EHR-integrated clinical decision support and medical-grade AI to connect healthcare providers and life sciences companies for chronic disease management.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Medical Devices, Healthcare Analytics, Vertical SaaS
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amalgam Rx Comparables
Compare Amalgam Rx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrightInsight | 87% | |
| Adhera Health | 86% | |
| Sidekick Health | 83% | |
Amalgam Rx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Aug 12, 2025 | ||||
| Series B | Oct 5, 2023 | ||||
| Series A | Dec 19, 2022 | ||||
| Series A | Sep 25, 2019 | ||||
| Seed | May 2, 2019 | ||||
VC Round | Jun 20, 2017 |
Key People
Founding team and executive leadership
Amalgam Rx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalio Capital Management | Debt |
| CVS Health Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 12, 2025
$20M debt round completed.
- Aug 12, 2025
Deal with Novo Nordisk to market Dose Check app globally.
Amalgam Rx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amalgam Rx's valuation, stock price, and market status.